A New Interactive Platform on European Health Research

A new online platform named HealthCompetence.eu has been presented at the Information day on FP7 Health Research organised by the European Commission. This new platform includes all projects related to life science and health supported by the European Commission since 2004. Far from being a static database, it aims to present the projects' latest results in terms of technology offers, patents and publications. The platform also offers a row of interactive search devices which facilitate the identification of potential collaboration partners and the set up of partnerships between academia and industry in health research. The prototype of the platform was launched during the BIO Conference in Chicago in May 2010 and has already raised a lot of interest.

Currently, the platform HealthCompetence.eu, which is supported by the European Commission, contains 3300 EU-funded projects. In contrary to other more static databases, it presents reliable and updated information on the projects: the results of the projects will be continuously updated thanks to cooperation agreements with top technology transfer organisations in Europe representing large research organizations such as Inserm, CNRS and the Karolinska Institutet. Therefore, the platform will contribute to a better dissemination of publicly funded research results. On top of that, it offers interesting functionalities for researchers and institutions.

At the BIO International Convention in Chicago, the prototype of the platform has attracted a lot of attention and has been seen as an important contribution to show the positive impact of research for innovation. Among others, the National Institutes of Health, which similarly to the European Commission strive after a successful and positive dissemination of scientific activities and results, have expressed their interest in joining HealthCompetence.eu as cooperation partners.

The platform HealthCompetence.eu is being implemented by a consortium of three partners: AVEDAS AG, Inserm Transfert SA and European Federation of Biotechnology. AVEDAS provides CONVERIS, its software platform for managing research information all along the research life cycle. Inserm Transfert SA, the private subsidiary the French National Institute of Health and Medical Research, has a strong experience in technology transfer, from invention disclosure to industrial partnership. The European Federation of Biotechnology, through its large membership, will strengthen the visibility of the output of the research activity supported by the European Union.

The database of HealthCompetence.eu currently includes 3300 EU-funded health research projects which have been carried out by 5002 partners from the EU and other parts of the world since 2004.

For further information, please visit:
http://www.healthcompetence.eu

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...